HomeCOLL • NASDAQ
add
Collegium Pharmaceutical Inc
Previous close
$34.50
Day range
$34.94 - $37.06
Year range
$23.23 - $50.79
Market cap
1.13B USD
Avg Volume
422.51K
P/E ratio
20.53
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 205.45M | 12.92% |
Operating expense | 119.08M | 4.35% |
Net income | 16.96M | 35.31% |
Net profit margin | 8.26 | 19.88% |
Earnings per share | 2.04 | 15.25% |
EBITDA | 118.11M | 17.97% |
Effective tax rate | 41.58% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 386.68M | 137.57% |
Total assets | 1.66B | -0.41% |
Total liabilities | 1.36B | -5.55% |
Total equity | 301.68M | — |
Shares outstanding | 31.75M | — |
Price to book | 3.63 | — |
Return on assets | 9.45% | — |
Return on capital | 12.60% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 16.96M | 35.31% |
Cash from operations | 123.05M | 45.37% |
Cash from investing | -20.07M | -70.63% |
Cash from financing | -21.82M | 47.14% |
Net change in cash | 81.16M | 156.79% |
Free cash flow | 139.17M | 5.03% |
About
Founded
2002
Website
Employees
423
